ABIOMED impella 5.5kit

Condition: New
Part #: REF 0048-0003

$82,000.00

SKU: REF 0048-0003 Categories: ,
MAKE AN OFFER
Description

The ABIOMED Impella 5.5 is a state-of-the-art percutaneous ventricular assist device (pVAD) engineered to provide critical mechanical circulatory support for patients with compromised left ventricular function. Designed for rapid deployment in high-stakes clinical environments, the Impella 5.5 facilitates hemodynamic stabilization during high-risk cardiac interventions and acute heart failure episodes. By actively pumping blood from the ventricle into the aorta, it enables profound myocardial unloading, allowing the heart a vital opportunity to rest and recover.

Core Technology: SmartAssist® Integration

At the heart of the Impella 5.5 system is the SmartAssist® technology platform. This integration transforms the device from a simple pump into a sophisticated diagnostic and therapeutic tool.

  • Real-Time Feedback: Optical pressure sensors provide continuous, precise data on pump positioning and cardiac output.

  • Hemodynamic Monitoring: The system monitors the patient’s native heart function alongside pump performance, allowing clinicians to make data-driven weaning decisions.

  • Optimized Positioning: Advanced algorithms help maintain the ideal placement across the aortic valve, minimizing the risk of suction or displacement.

Mechanism of Action

The Impella 5.5 utilizes a micro-axial flow pump to physically decompress the left ventricle. Unlike passive support systems, it actively pulls blood from the left ventricular cavity and expels it into the ascending aorta. This mechanism provides three primary clinical benefits:

  1. Increased Systemic Perfusion: Delivers a maximum flow rate of 4.3 L/min, ensuring vital organs receive oxygenated blood.

  2. Reduced Cardiac Workload: By lowering end-diastolic pressure and volume, it reduces the wall tension and oxygen demand of the myocardium.

  3. Enhanced Coronary Flow: Improved aortic pressure profiles directly increase perfusion to the heart’s own arteries.

Clinical Applications and Uses

The Impella 5.5 kit is indicated for use in a variety of acute cardiac scenarios where the native heart cannot maintain sufficient output:

  • High-Risk Percutaneous Coronary Intervention (PCI): Providing stability during complex stenting or angioplasty.

  • Cardiogenic Shock: Rapidly reversing hemodynamic instability following an acute myocardial infarction or as a result of cardiomyopathy.

  • Post-Cardiotomy Recovery: Supporting the heart as it recovers from the “stunning” effects of cardiac surgery.

  • Acute Decompensated Heart Failure: Bridging patients toward recovery or further advanced therapies.

Key Advantages: Impella 5.5 vs. Traditional IABP

The Impella 5.5 offers significant physiological advantages over traditional Intra-Aortic Balloon Pumps (IABP).

Feature Impella 5.5 Intra-Aortic Balloon Pump (IABP)
Max Flow Rate Up to 4.3 L/min ~0.5 L/min (approximate)
LV Unloading Active (Directly reduces volume) Passive (Displacement only)
Monitoring SmartAssist® (Real-time data) Limited / Basic pressure tracing
Support Type Continuous flow Pulsatile counterpulsation

Treatment Process and Deployment

Deployment of the Impella 5.5 is designed for efficiency and safety in the cardiac catheterization lab or operating room.

  1. Access: The device is typically inserted via a minimally invasive 14F femoral access site using a standard percutaneous technique.

  2. Positioning: Guided by fluoroscopy or echocardiography, the pump is advanced through the aorta and across the aortic valve.

  3. Activation: Once positioned, the pump is initiated, and flow is titrated based on the patient’s hemodynamic requirements.

  4. Management: The patient is monitored via the Automated Impella Controller (AIC) for up to four days of continuous support.

Technical Specifications

The Impella 5.5 kit is optimized for performance while maintaining a low-profile footprint to minimize vascular complications.

  • Maximum Flow: 4.3 Liters per minute (L/min)

  • Insertion Size: 14 French (14F)

  • Catheter Platform: 9 French (9F)

  • Duration of Use: Up to 4 days (short-term support)

  • Integrated Sensors: Optical pressure sensors for SmartAssist®

  • Compatibility: Automated Impella Controller (AIC)


Frequently Asked Questions

What is the primary function of the ABIOMED Impella 5.5?

The Impella 5.5 is designed to provide temporary mechanical circulatory support by actively pumping blood from the left ventricle to the aorta. It supports patients with reduced heart function during high-risk procedures or acute heart failure, ensuring adequate systemic perfusion while allowing the heart muscle to rest and recover.

How does the Impella 5.5 differ from a standard heart pump?

Unlike larger surgical VADs, the Impella 5.5 is a percutaneous device, meaning it is inserted through a small incision in the leg (14F access). It is specifically engineered for short-term support (up to 4 days) and features SmartAssist technology for real-time monitoring of cardiac hemodynamics and pump placement.

What are the benefits of the SmartAssist technology?

SmartAssist provides clinicians with real-time, pressure-based feedback and advanced hemodynamic data directly on the console. This allows for precise pump positioning, better management of the patient’s weaning process, and improved overall outcomes by ensuring the device is performing optimally relative to the patient’s native heart rhythm.

Is the Impella 5.5 insertion procedure invasive?

The insertion is considered minimally invasive compared to traditional open-heart surgical assist devices. It utilizes a 14F femoral insertion technique, allowing the device to be deployed in a catheterization lab or operating room. This approach reduces recovery time and the potential for the complications associated with more invasive surgeries.

How much flow can the Impella 5.5 provide?

The Impella 5.5 delivers a maximum flow rate of 4.3 L/min. This level of support is significantly higher than that of an Intra-Aortic Balloon Pump (IABP), providing enough circulatory volume to stabilize most adult patients in cardiogenic shock or those undergoing extremely high-risk coronary interventions.

What is the maximum duration for Impella 5.5 support?

The device is indicated for short-term use, providing continuous hemodynamic support for a duration of up to four days. During this period, the medical team monitors the patient for signs of myocardial recovery, at which point the device can be gradually weaned and removed percutaneously.

Listing Terms & Conditions

We ship worldwide, please inquire the shipping rate to your country before placing an order.

We carry all products of this brand in the listing, please let me know if you have any other inquires which is not listed in our store.

All purchases over $1,000 must be paid by wire transfer. We cannot accept international credit card payments for orders over $1,000.

Due to worldwide shipping delays, it is possible that items listed could be on backorder. If the item is unavailable for an extended period, we sincerely apologize for the delay. In this case, we will refund you as soon as we are notified of the backorder and contact you with the confirmation of refund.